Expression profiles of microRNAs in midbrain of MPTP-treated mice determined by microRNA sequencing

Neurosci Lett. 2022 Sep 25:788:136841. doi: 10.1016/j.neulet.2022.136841. Epub 2022 Aug 19.

Abstract

MPTP models have been developed to mimic human Parkinson's disease and serve as an indispensable tool for studying PD. Among them, subacute MPTP PD models are popular due to their short modeling period and similarity to PD pathology. However, the early pathophysiological mechanism of the model remains to be further clarified. More and more studies have shown that dysregulation of miRNAs plays an important role in the occurrence and development of neurodegenerative diseases, including PD. In this study, we identified 43 differentially expressed microRNAs (miRNAs) in the ventral midbrain of MPTP-induced subacute PD mouse by RNA sequencing. Further bioinformatics analysis revealed that these miRNAs were significantly enriched in axon guidance/neuron projection, metabolic pathways/cellular macromolecule metabolic process and PI3K/AKT signaling pathways, which were involved in the occurrence and development of early PD. Thus, targeted regulation of these miRNAs may reverse the neurodegeneration of early PD.

Keywords: MPTP; Parkinson’s disease; miRNAs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Animals
  • Disease Models, Animal
  • Dopaminergic Neurons / metabolism
  • Humans
  • Mesencephalon / metabolism
  • Mice
  • Mice, Inbred C57BL
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Parkinson Disease* / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism

Substances

  • MicroRNAs
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine